How pharmaceutical brands can be resilient
While inflation and economic pressures force pharmaceutical brands to watch their pennies, they will do well to not tackle cost efficiency as a solo issue. Brands require resilience in various areas, and chief among these is compliance. Stringent regulations must be followed, although the supply chains from which they are navigated, are incredibly complex.
So, can brands manage resilience factors, such as costs and compliance, holistically?